Literature DB >> 35411469

Difficult to evaluate the effect of remimazolam.

Hong Liang1, Jing An2, Xiao Yang3.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35411469     DOI: 10.1007/s00540-022-03065-4

Source DB:  PubMed          Journal:  J Anesth        ISSN: 0913-8668            Impact factor:   2.931


× No keyword cloud information.
  1 in total

1.  Remimazolam decreased the incidence of early postoperative nausea and vomiting compared to desflurane after laparoscopic gynecological surgery.

Authors:  Yuki Hari; Shiho Satomi; Chiaki Murakami; Soshi Narasaki; Atsushi Morio; Takahiro Kato; Yasuo M Tsutsumi; Nami Kakuta; Katsuya Tanaka
Journal:  J Anesth       Date:  2022-02-10       Impact factor: 2.931

  1 in total
  1 in total

1.  Reply to the letter titled "Difficult to evaluate the effect of remimazolam".

Authors:  Nami Kakuta; Shiho Satomi; Yasuo M Tsutsumi
Journal:  J Anesth       Date:  2022-05-12       Impact factor: 2.931

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.